Mammoth Biosciences researchers have developed NanoCas, an ultracompact CRISPR nuclease, demonstrating its ability to perform ...

The CRISPR-Cas9 system offers groundbreaking genome editing capabilities, yet off-target cleavage raises concerns about ...

Bondi was born in 1965 in Tampa, Florida, and graduated from King High School in 1983. In 1987, she received a bachelor's degree in criminal justice from the University of Florida, and in 1990, she ...

Pam Windsor is a journalist covering all things music. Based in Nashville, TN, she’s written for Forbes.com since 2018. Her extensive journalism background includes more than two decades in TV ...

Both Cas9 and Cas12a cleave DNA, but they differ in how they cut the molecule.

An extensive arsenal of biosensing tools has been developed based on the clustered regularly interspaced short palindromic repeat (CRISPR) platform ... to sensitively detect unique copies of a target ...

Hossain and coworkers investigate the mechanisms of recognition of xCas9, a variant of Cas9 with expanded targeting capability ... why xCas9 exhibits improved recognition of the TGG PAM sequence ...

Division of Multi-Organ Transplantation, Department of Surgery, University of California, San Francisco, San Francisco, United States Bakar Computational Health Sciences Institute, University of ...

CRISPR technology has revolutionized genetic testing and disease detection, offering precise, rapid, and cost-effective diagnostic solutions. This gene-editing tool has been adapted for molecular ...

Zhi-Kun Li at the Chinese Academy of Sciences in Beijing and his colleagues used CRISPR to create the mice, using a novel approach to target genes that normally need to be inherited from both male ...

Update: On Feb. 4, 2025, the U.S. Senate confirmed Pam Bondi as U.S. attorney general. After President Donald Trump tapped Pam Bondi to serve as the next U.S. attorney general, the Reporters Committee ...

CRISPR Therapeutics AG (CRSP) closed at $43.42 in the latest trading session, marking a -1.83% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 0.29%.